DOC

What DOC does

DOC - Documentation Organization & Consultancy is an Italy-based professional services firm providing consultancy, qualification, and validation services to biopharmaceutical manufacturers. Founded in 1997 and headquartered in Settala (Milan), the company operates as a wholly-owned subsidiary of Masco Group, a diversified pharmaceutical and biotech services conglomerate. Its stated mission is to bridge the gap between clients' manufacturing processes and regulatory requirements, with deep specialisation in cGMP compliance, process validation, system qualification, and computerized system validation.

The company's service portfolio is organised across three business units: Commissioning, Qualification & Validation (CQV), which covers equipment and system qualification for regulated manufacturing environments; MascoLab, a laboratory validation arm offering filter validation, primary packaging qualification, and in-process materials qualification testing; and Training & Education, which delivers seminars and training programmes to pharma personnel. Underlying service work relies on documented regulatory frameworks (cGMP, computerized system validation protocols) and on-the-ground laboratory testing rather than a proprietary software platform. Across 25+ years, DOC claims 3500+ completed projects worldwide and 400+ training and seminar sessions delivered globally.

DOC operates a professional services revenue model with quote-based, tailored pricing per engagement. Its go-to-market is enterprise field sales via direct consultancy engagement, targeting pharmaceutical and biotech companies requiring validation and compliance support. Marketing is conducted primarily through the parent Masco Group's digital properties (website, LinkedIn, resource library, industry events). The company has no publicly disclosed revenue, no disclosed external investors, no management team profiles in the source data, and no named customer logos; its value proposition is anchored on regulatory expertise, talent credentials, and integration with the broader Masco Group ecosystem (which also includes automation, digitalization, and equipment brands such as BCD, KeyPlants, MGA, Olsa, Stilmas, VILS, and Techniserv).

Name

DOC

Legal name

DOC - Documentation Organization & Consultancy

Website

https://docvalidation.it

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

51–100 employees

Short description

DOC is an Italy-based pharma consultancy and subsidiary of Masco Group that provides cGMP compliance, qualification, validation, and laboratory testing services to biopharmaceutical manufacturers worldwide.

Ownership category

akta.pro rank

Product category

Pharmaceutical Validation and Regulatory Compliance Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Testing Laboratories (8734)

akta.pro primary industry

Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11) (HLAGAKAG)

akta.pro secondary industry

Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI)

Keywords

• Pharmaceutical validation services
• GMP compliance consulting
• Equipment qualification services
• Laboratory validation testing
• Biopharmaceutical regulatory consultancy

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Consultancy Services: Professional consultancy services for pharmaceutical and biotech clients providing qualification, validation, and compliance expertise

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

DOC delivers consultancy, qualification, and validation services for biopharmaceutical manufacturers, helping clients achieve cGMP compliance and navigate regulatory requirements. Its offering centers on three business units: Commissioning, Qualification & Validation (CQV) for equipment and systems, MascoLab for laboratory validation (filter validation, primary packaging qualification, in-process materials qualification), and Training & Education programs for the pharmaceutical industry.

Product overview

DOC offers a portfolio of consultancy, qualification, and validation services as a single unified offering rather than a modular software platform. The three core business units are Commissioning, Qualification & Validation (CQV), MascoLab laboratory validation services, and Training & Education. These services work together to help biopharmaceutical clients achieve compliance with cGMP standards and navigate regulatory challenges.

Differentiator

Problem solved

Functional benefit

Brands

• MascoLab: Laboratory validation services division offering filter validation, primary packaging qualification, and in-process materials qualification services.
• Commissioning, Qualification & Validation (CQV)
• Training & Education

Products and services

• Commissioning, Qualification & Validation (CQV) Comprehensive commissioning, qualification, and validation services for equipment and systems in pharmaceutical manufacturing environments, helping biopharmaceutical clients achieve compliance with cGMP standards and regulatory requirements. Includes Computerised System Validation and Validation Maintenance offerings.
• MascoLab Laboratory Validation Laboratory validation services including filter validation and ancillary tests, primary packaging qualification and ancillary tests, and in-process materials qualification and ancillary tests for biopharmaceutical manufacturers.
• Training and Education Training and educational programs for the pharmaceutical industry, with more than 400 training sessions and seminars organized worldwide covering cGMP compliance, validation methodologies, and regulatory best practices.

Quantifiable outcome

• 3500+ projects completed worldwide
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves3 records

Expansion highlights4 records

Direct peers

• NNE: NNE is a Novo Nordisk-founded pharma engineering consultancy providing project execution, validation, and qualification services worldwide. Comparable to DOC on commissioning, qualification, and validation work for regulated manufacturing facilities across the biopharma supply chain.
• ProPharma Group: ProPharma Group provides regulatory affairs, GxP compliance, computerized system validation, and life sciences consulting services to biopharma manufacturers. It competes directly with DOC on CSV and cGMP compliance mandates and offers a similarly integrated consulting-and-validation model to enterprise pharma clients.
• Tunnell Consulting: Tunnell Consulting is a U.S.-based life sciences consulting firm specializing in operational excellence, validation, and regulatory compliance for pharma and biotech manufacturers. Directly comparable to DOC on process validation and cGMP-related transformation mandates.
• Commissioning Agents Inc (CAI): Commissioning Agents Inc (CAI) is one of the largest dedicated CQV and engineering service firms for the pharmaceutical industry, with global delivery across the U.S., Europe, and Asia. Directly comparable to DOC's CQV and CSV offerings, serving the same biopharma compliance buyer and competing head-to-head on multi-year qualification programs.
• PharmEng Technology (Clueo): PharmEng Technology (rebrand Clueo) provides pharmaceutical training, validation, regulatory affairs, and GxP consulting to manufacturers globally. Directly comparable to DOC on validation services and training curriculum, with similar reliance on biopharma clients.

Broad incumbents

• IQVIA: IQVIA is a global CRO and life sciences services giant with substantial regulatory, compliance, and technology validation capabilities. While not a pure validation firm, IQVIA competes for large pharma consulting budgets that overlap with DOC's enterprise buyer segment.
• Eli Lilly and Company - Engineering Services: Major global engineering consultancies (Worley, Jacobs, ICON) operate life sciences practices that deliver CQV and validation at scale. These broad incumbents outflank DOC on enterprise mega-deals and may squeeze DOC into subcontractor roles on global accounts.

Others

• Stilmas (Masco Group sibling): Stilmas, a sister brand of DOC within Masco Group, designs and manufactures purified water and sterile systems for pharma. While it sells equipment rather than validation services, its projects commonly require DOC's qualification work, making it the most natural cross-reference within the Masco ecosystem.
• KeyPlants (Masco Group sibling): KeyPlants, another Masco Group sister company, delivers modular cleanroom and pharma facility construction. Its projects create direct downstream demand for DOC's CQV services, making it the most relevant internal ecosystem peer rather than a competitive match.

Emerging players

• Cobham Life Sciences Validation Services: Emerging mid-sized validation and quality consultancies (Cobham's validation practice, Validant) compete for the same mid-market biopharma CSV and quality mandates as DOC. Comparable on regulatory expertise but typically serve a more geographically concentrated client base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/doc-srl

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DOC